“`html
Cervical Cancer Elimination: Progress, Challenges, and the WHO’s 90-70-90 Strategy
Table of Contents
Each year, more than 340,000 women die from cervical cancer, with the majority of deaths occurring in low- and middle-income countries.Despite being highly preventable through vaccination and early detection, the disease remains the fourth most common cancer among women. In 2020, the World Health Association (WHO) launched the Global Strategy to Accelerate the Elimination of Cervical Cancer, setting aspiring “90-70-90” targets for vaccination, screening, and treatment by 2030. Yet vast inequities in health resources, infrastructure, and access to care continue to hinder progress.
Understanding Cervical Cancer
Cervical cancer develops in the cells of the cervix, the lower part of the uterus. Almost all cases of cervical cancer are caused by persistent infection with high-risk types of Human Papillomavirus (HPV) . HPV is a common sexually transmitted infection,and while most infections clear on their own,some can lead to precancerous changes and eventually cancer if left untreated.
Risk Factors
Several factors can increase the risk of developing cervical cancer,including:
- HPV infection
- Smoking
- Weakened immune system
- Long-term use of oral contraceptives
- Multiple sexual partners
- Early age at first sexual intercourse
The WHO’s 90-70-90 Elimination Strategy
The WHO’s Global Strategy to Accelerate the elimination of Cervical Cancer aims to eliminate the disease as a public health problem by 2030. This ambitious goal is built around three key targets, represented as “90-70-90”:
- 90% vaccination coverage: 90% of girls vaccinated against HPV by the age of 15.
- 70% screening coverage: 70% of women aged 35-45 screened for cervical cancer.
- 90% treatment coverage: 90% of women identified with cervical disease receive appropriate treatment.
Achieving these targets requires a comprehensive approach, including strengthening healthcare systems, increasing awareness, and ensuring equitable access to services.
Progress and Challenges
While significant progress has been made in some areas, the global elimination strategy faces considerable challenges.
Progress
- HPV Vaccine Development: The development and widespread availability of HPV vaccines are a major breakthrough in cervical cancer prevention.
- Increased Awareness: Growing awareness of cervical cancer and it’s prevention methods is leading to increased demand for vaccination and screening.
- Screening Programs: Many countries are implementing or expanding cervical cancer screening programs, utilizing methods like Pap tests and HPV testing.
Challenges
- Vaccine Access: Access to HPV vaccines remains limited in many low- and middle-income countries due to cost and logistical challenges.
- Screening Infrastructure: Lack of adequate screening infrastructure, trained personnel, and quality control systems hinders effective screening programs.
- Treatment Availability: Access to timely and appropriate treatment for cervical precancer and cancer is ofen limited, particularly in resource-constrained settings.
- Equity and Access: Significant disparities exist in access to cervical cancer prevention and treatment services based on socioeconomic status, geographic location
Worth a look